Literature DB >> 28583732

Effects of topical negative pressure therapy on tissue oxygenation and wound healing in vascular foot wounds.

Nathaniel Chiang1, Odette A Rodda2, Jamie Sleigh1, Thodur Vasudevan1.   

Abstract

OBJECTIVE: Topical negative pressure (TNP) therapy is widely used in the treatment of acute wounds in vascular patients on the basis of proposed multifactorial benefits. However, numerous recent systematic reviews have concluded that there is inadequate evidence to support its benefits at a scientific level. This study evaluated the changes in wound volume, surface area, depth, collagen deposition, and tissue oxygenation when using TNP therapy compared with traditional dressings in patients with acute high-risk foot wounds.
METHODS: This study was performed with hospitalized vascular patients. Forty-eight patients were selected with an acute lower extremity wound after surgical débridement or minor amputation that had an adequate blood supply without requiring further surgical revascularization and were deemed suitable for TNP therapy. The 22 patients who completed the study were randomly allocated to a treatment group receiving TNP or to a control group receiving regular topical dressings. Wound volume and wound oxygenation were analyzed using a modern stereophotographic wound measurement system and a hyperspectral transcutaneous oxygenation measurement system, respectively. Laboratory analysis was conducted on wound biopsy samples to determine hydroxyproline levels, a surrogate marker to collagen.
RESULTS: Differences in clinical or demographic characteristics or in the location of the foot wounds were not significant between the two groups. All patients, with the exception of two, had diabetes. The two patients who did not have diabetes had end-stage renal failure. There was no significance in the primary outcome of wound volume reduction between TNP and control patients on day 14 (44.2% and 20.9%, respectively; P = .15). Analyses of secondary outcomes showed a significant result of better healing rates in the TNP group by demonstrating a reduction in maximum wound depth at day 14 (36.0% TNP vs 17.6% control; P = .03). No significant findings were found for the other outcomes of changes in hydroxyproline levels (58.0% TNP vs 94.5% control; P = .32) or tissue perfusion by tissue oxyhemoglobin saturation (19.4% TNP vs 12.0% control; P = .07) at day 14. At 1 year of follow-up, there were no significant outcomes in the analysis of wound failure, major amputation, and overall survival rates between the two groups.
CONCLUSIONS: In this pilot study, applying TNP to acute high-risk foot wounds in patients with diabetes or end-stage renal failure improved the wound healing rate in reference to wound depth. This suggests that TNP may play a role in enhancing wound healing. This study sets the foundation for larger studies to evaluate the superiority of TNP over traditional dressings in high-risk foot wounds.
Copyright © 2017 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28583732     DOI: 10.1016/j.jvs.2017.02.050

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  11 in total

1.  Hyperspectral imaging in wound care: A systematic review.

Authors:  Gennadi Saiko; Phoebe Lombardi; Yunghan Au; Douglas Queen; David Armstrong; Keith Harding
Journal:  Int Wound J       Date:  2020-08-23       Impact factor: 3.315

2.  Intraoperative multispectral and hyperspectral label-free imaging: A systematic review of in vivo clinical studies.

Authors:  Jonathan Shapey; Yijing Xie; Eli Nabavi; Robert Bradford; Shakeel R Saeed; Sebastien Ourselin; Tom Vercauteren
Journal:  J Biophotonics       Date:  2019-04-29       Impact factor: 3.207

3.  Effect of Micropower Vacuum Dressing on Promoting Wound Healing in Patients with I-II Diabetic Foot.

Authors:  Cunren Chen; Xixiong Wang; Changli Liang; Haiwei Liu
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-06       Impact factor: 2.650

Review 4.  Negative pressure wound therapy for surgical wounds healing by primary closure.

Authors:  Gill Norman; Chunhu Shi; En Lin Goh; Elizabeth Ma Murphy; Adam Reid; Laura Chiverton; Monica Stankiewicz; Jo C Dumville
Journal:  Cochrane Database Syst Rev       Date:  2022-04-26

5.  Negative pressure wound therapy for surgical wounds healing by primary closure.

Authors:  Joan Webster; Zhenmi Liu; Gill Norman; Jo C Dumville; Laura Chiverton; Paul Scuffham; Monica Stankiewicz; Wendy P Chaboyer
Journal:  Cochrane Database Syst Rev       Date:  2019-03-26

6.  Negative pressure wound therapy for surgical wounds healing by primary closure.

Authors:  Gill Norman; En Lin Goh; Jo C Dumville; Chunhu Shi; Zhenmi Liu; Laura Chiverton; Monica Stankiewicz; Adam Reid
Journal:  Cochrane Database Syst Rev       Date:  2020-05-01

7.  Negative pressure wound therapy reduces the motility of Pseudomonas aeruginosa and enhances wound healing in a rabbit ear biofilm infection model.

Authors:  Wang Guoqi; Li Zhirui; Wang Song; Li Tongtong; Zhang Lihai; Zhang Licheng; Tang Peifu
Journal:  Antonie Van Leeuwenhoek       Date:  2018-02-21       Impact factor: 2.271

8.  Negative pressure wound therapy in patients with wounds healing by secondary intention: a systematic review and meta-analysis of randomised controlled trials.

Authors:  Yvonne Zens; Michael Barth; Heiner C Bucher; Katrin Dreck; Moritz Felsch; Wolfram Groß; Thomas Jaschinski; Heike Kölsch; Mandy Kromp; Inga Overesch; Stefan Sauerland; Sven Gregor
Journal:  Syst Rev       Date:  2020-10-10

9.  Negative pressure wound therapy for surgical wounds healing by primary closure.

Authors:  Gill Norman; En Lin Goh; Jo C Dumville; Chunhu Shi; Zhenmi Liu; Laura Chiverton; Monica Stankiewicz; Adam Reid
Journal:  Cochrane Database Syst Rev       Date:  2020-06-15

10.  Negative-Pressure Wound Therapy in a Pseudomonas aeruginosa Infection Model.

Authors:  Guoqi Wang; Zhirui Li; Tongtong Li; Song Wang; Lihai Zhang; Licheng Zhang; Peifu Tang
Journal:  Biomed Res Int       Date:  2018-05-15       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.